期刊
THERANOSTICS
卷 2, 期 12, 页码 1117-1126出版社
IVYSPRING INT PUBL
DOI: 10.7150/thno.4381
关键词
nanotheranostics; liposomes; polymeric nanoparticles; magnetic resonance imaging; radionuclide imaging; fluorescence imaging
资金
- National Science Foundation [DMR-1216461, CMMI-1031239]
- Division Of Materials Research [1216461] Funding Source: National Science Foundation
The relatively new field of nanotheranostics combines the advantages of in vivo diagnosis with the ability to administer treatment through a single nano-sized carrier, offering new opportunities for cancer diagnosis and therapy. Nanotheranostics has facilitated the development of nanomedicine through direct visualization of drug blood circulation and biodistribution. From a clinical perspective, nanotheranostics allows therapies to be administered and monitored in real time, thus decreasing the potential of under- or over-dosing and allowing for more personalized treatment regimens. Herein, we review recent development of nanotheranostics using lipid-and polymer-based formulations, with a particular focus on their applications in cancer research. Recent advances in nanotechnology aimed to combine therapeutic molecules with imaging agents for magnetic resonance imaging, radionuclide imaging, or fluorescence imaging are discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据